chevron_leftBack
As of 13 June 2026, Atrium Therapeutics, Inc. has a market cap of $211.6M USD, ranking #20701 globally and #3387 in the United States.
It ranks #1860 in the Healthcare sector, and #360 in the Biotechnology industry.
Key Stats
Market Cap
$211.6MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | 0.6% | -5.6% | -15% | -15% | -15% |
News
Loading...
RNA Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
RNA
ISIN: US04965N1046
Shares Out.:
Shares Outstanding:
17.106M1
Shares Float:
17.069M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
12.37 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
86K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
75K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
13K%
|
-
|
|
NYSE: IQV
|
$26.3B
12K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
12K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
8K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
23K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
21K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
20K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
20K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
13K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
12K%
|
-
|
chevron_leftBack